OTCM
CLLKF
Market cap165mUSD
Oct 20, Last price
2.40USD
Name
BICO Group AB
Chart & performance
P/E
—
P/S
1.10
EPS
—
Vol. 1Y
—
Shs. 5Y
10.81%
Rev. 5Y
53.31%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.50b
-23.07%
Net income
-1.09b
L+19,698.18%
CFO
68m
-56.82%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BICO Group AB (publ) is a global bio-convergence enterprise, conducting operations across North America, Europe, Asia, and other international markets. Its business is structured into two main divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions segment delivers a range of advanced equipment, including 3D bioprinters, hybrid microscopy systems, single-cell dispensing instruments, and liquid handling devices. This division also supplies essential consumables such as bioinks, reagents, microscope lenses, software, printheads, and even 3D reconstructed human tissues, particularly for applications in regulatory testing. Furthermore, Laboratory Solutions offers specialized services like 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology, primarily serving pharmaceutical and biotechnology companies. Conversely, the Bioautomation segment caters to industrial customers with products focused on precision dispensing and innovative biosensor technology. It also provides sophisticated diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. Overall, BICO Group's offerings include comprehensive solutions for industrial ecosystems, tissue engineering, multi-omics analysis, cell line development, and diagnostics. Its primary clientele originates from the medical, pharmaceutical, and cosmetic sectors. Founded in 2016 and headquartered in Gothenburg, Sweden, the company was previously known as Cellink AB (publ) before officially changing its name to BICO Group AB (publ) in August 2021.
Key people
President, Chief Executive Officer · since 2023
Ewa Linsater
Chief Financial Officer · since 2026
Marius Balger
Chief Operating Officer · since 2023
Jesper Hagberg
Chief Operations and Digital Officer · since 2026
Lars Risberg
General Counsel · since 2025
Anders Fogelberg
Chief Commercial Officer · since 2024
Catharina Nordlund
Global Head of Human Resources · since 2024
Alexandra Gatzemeyer
Independent Director · since 2024
Independent Director · since 2025
Independent Chairman of the Board · since 2025
Bengt Sjoholm
Independent Director · since 2016
Susan Tousi
Independent Director · since 2021
Johan Westman
Independent Director · since 2025
Christian Wildmoser
Independent Director · since 2019
Headquarters & legal address
Grafiska vägen 2B
Göteborg, O 412 63
SE
Göteborg, O 412 63
SE
Address
Grafiska vagen 2B
Goteborg, O 412 63
SE
Goteborg, O 412 63
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||